Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Schizophrenia

  Free Subscription


Articles published in Acta Psychiatr Scand

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    September 2022
  1. SANCHEZ-GUTIERREZ T, Barbeito S, Gomez-Juncal R, Rodriguez-Ortega E, et al
    Neuropsychological Functioning and Suicidal Behaviours in Patients with First-Episode Psychosis: A Systematic Review.
    Acta Psychiatr Scand. 2022 Sep 25. doi: 10.1111/acps.13501.
    PubMed     Abstract available


  2. PURANEN A, Koponen M, Lahteenvuo M, Tanskanen A, et al
    Real-world effectiveness of mood stabilizer use in schizophrenia.
    Acta Psychiatr Scand. 2022 Sep 5. doi: 10.1111/acps.13498.
    PubMed     Abstract available


  3. STOGIOS N, Maksyutynska K, Navagnanavel J, Sanches M, et al
    Metformin for the prevention of clozapine-induced weight gain: A retrospective naturalistic cohort study.
    Acta Psychiatr Scand. 2022;146:190-200.
    PubMed     Abstract available


    July 2022
  4. GYLLENBERG D, Ristikari T, Kelleher I, Kaariala A, et al
    School Performance and Later Diagnoses of Non-Affective Psychoses, Bipolar Disorder and Depression.
    Acta Psychiatr Scand. 2022 Jul 25. doi: 10.1111/acps.13481.
    PubMed     Abstract available


  5. BENROS ME
    High-quality large-scale longitudinal studies with detailed multimodal immunological phenotyping are warranted to disentangle the involvement of the immune system in psychosis.
    Acta Psychiatr Scand. 2022;146:3-5.
    PubMed    


    May 2022
  6. FACAL F, Arrojo M, Paz E, Paramo M, et al
    Association between psychiatric hospitalizations of patients with schizophrenia and polygenic risk scores based on genes with altered expression by antipsychotics.
    Acta Psychiatr Scand. 2022 May 18. doi: 10.1111/acps.13444.
    PubMed     Abstract available


    April 2022
  7. BAANDRUP L, Allerup P, Nielsen MO, During SW, et al
    Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models.
    Acta Psychiatr Scand. 2022 Apr 13. doi: 10.1111/acps.13434.
    PubMed     Abstract available


    March 2022
  8. SPILKA MJ, Keller WR, Buchanan RW, Gold JM, et al
    Endogenous oxytocin levels are associated with facial emotion recognition accuracy but not gaze behavior in individuals with schizophrenia.
    Acta Psychiatr Scand. 2022 Mar 4. doi: 10.1111/acps.13421.
    PubMed     Abstract available


    February 2022
  9. DUNLEAVY C, Elsworthy RJ, Upthegrove R, Wood SJ, et al
    Inflammation in First-Episode Psychosis: The Contribution of Inflammatory Biomarkers to the Emergence of Negative Symptoms, A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2022 Feb 24. doi: 10.1111/acps.13416.
    PubMed     Abstract available


  10. MORENO-KUSTNER B, Fabrega-Ruz J, Gonzalez-Caballero JL, Reyes S, et al
    The Patient-Reported Impact of Symptoms in Schizophrenia Scale (PRISS): Development and Validation.
    Acta Psychiatr Scand. 2022 Feb 21. doi: 10.1111/acps.13417.
    PubMed     Abstract available


  11. VERDOLINI N, Borras R, Sparacino G, Garriga M, et al
    The prodromal phase: Differences in prodromal symptoms, risk factors and markers of vulnerability in first episode mania versus first episode psychosis with onset in late adolescence or adulthood.
    Acta Psychiatr Scand. 2022 Feb 16. doi: 10.1111/acps.13415.
    PubMed     Abstract available


  12. BRODEUR S, Vanasse A, Courteau J, Stip E, et al
    Comparative Effectiveness and Safety of Antipsychotic Drugs in Patients with Schizophrenia Initiating or Reinitiating Treatment: A Real-World Observational Study.
    Acta Psychiatr Scand. 2022 Feb 14. doi: 10.1111/acps.13413.
    PubMed     Abstract available


  13. TESLI M, Degerud E, Plana-Ripoll O, Gustavson K, et al
    Educational attainment and mortality in schizophrenia.
    Acta Psychiatr Scand. 2022 Feb 13. doi: 10.1111/acps.13407.
    PubMed     Abstract available


  14. BRODEUR S, Vanasse A, Courteau J, Courteau M, et al
    Antipsychotic Utilization Trajectories Three Years After Initiating or Reinitiating Treatment of Schizophrenia: A State Sequence Analysis Approach.
    Acta Psychiatr Scand. 2022 Feb 12. doi: 10.1111/acps.13411.
    PubMed     Abstract available


    January 2022
  15. MURILLO-GARCIA N, Diaz-Pons A, Fernandez-Cacho LM, Miguel-Cossrredera M, et al
    A family study on first episode of psychosis patients: exploring neuropsychological performance as an endophenotype.
    Acta Psychiatr Scand. 2022 Jan 25. doi: 10.1111/acps.13404.
    PubMed     Abstract available


  16. BALLESTER PL, Romano MT, de Azevedo Cardoso T, Hassel S, et al
    Brain age in mood and psychotic disorders: a systematic review and meta-analysis.
    Acta Psychiatr Scand. 2022;145:42-55.
    PubMed     Abstract available


    December 2021
  17. LOPEZ-DIAZ A, Ayesa-Arriola R, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, et al
    Predictors of diagnostic stability in brief psychotic disorders: Findings from a 3-year longitudinal study.
    Acta Psychiatr Scand. 2021;144:578-588.
    PubMed     Abstract available


    November 2021
  18. NIELSEN J
    Clozapine treatment in a wider context: From before eligibility to life beyond clozapine.
    Acta Psychiatr Scand. 2021;144:419-421.
    PubMed    


  19. SISKIND D, Sharma M, Pawar M, Pearson E, et al
    Clozapine levels as a predictor for therapeutic response: A systematic review and meta-analysis.
    Acta Psychiatr Scand. 2021;144:422-432.
    PubMed     Abstract available


    October 2021
  20. MUSTAFA SS, Malla A, Joober R, Abadi S, et al
    Unfinished business: Functional outcomes in a randomized controlled trial of a three-year extension of early intervention versus regular care following two years of early intervention for psychosis.
    Acta Psychiatr Scand. 2021 Oct 2. doi: 10.1111/acps.13377.
    PubMed     Abstract available


    September 2021
  21. PARK CI, Han M, Jung I, Kim EH, et al
    A nationwide nested case-control study of new-onset obsessive-compulsive disorder following antipsychotics use in schizophrenia.
    Acta Psychiatr Scand. 2021 Sep 26. doi: 10.1111/acps.13375.
    PubMed     Abstract available


    August 2021
  22. SMITH E, Singh R, Lee J, Colucci L, et al
    Adiposity in Schizophrenia: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 Aug 30. doi: 10.1111/acps.13365.
    PubMed     Abstract available


  23. KRISTENSEN TD, Glenthoj LB, Ambrosen K, Syeda W, et al
    Global fractional anisotropy predicts transition to psychosis after 12 months in individuals at ultra-high risk for psychosis.
    Acta Psychiatr Scand. 2021 Aug 1. doi: 10.1111/acps.13355.
    PubMed     Abstract available


  24. HSU CW, Tseng PT, Tu YK, Lin PY, et al
    Month of birth and mental disorders: A population-based study and validation using global meta-analysis.
    Acta Psychiatr Scand. 2021;144:153-167.
    PubMed     Abstract available


    July 2021
  25. FUJIWARA M, Yamada Y, Shimazu T, Kodama M, et al
    Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial.
    Acta Psychiatr Scand. 2021 Jul 9. doi: 10.1111/acps.13348.
    PubMed     Abstract available


  26. SUAREZ-PINILLA P, Suarez-Pinilla M, Setien-Suero E, Ortiz-Garcia de la Foz V, et al
    Stability of schizophrenia diagnosis in a ten-year longitudinal study on first episode of non-affective psychosis: conclusions from the PAFIP cohort.
    Acta Psychiatr Scand. 2021 Jul 6. doi: 10.1111/acps.13344.
    PubMed     Abstract available


  27. BARCELLA CA, Polcwiartek C, Mohr GH, Hodges G, et al
    Severe mental illness is associated with increased mortality and severe course of COVID-19.
    Acta Psychiatr Scand. 2021;144:82-91.
    PubMed     Abstract available


    June 2021
  28. BHAVSAR V, Kepinska AP
    Schizophrenia, catatonic schizophrenia and poliovirus - a role for natural experiments?
    Acta Psychiatr Scand. 2021;143:469-471.
    PubMed    


    May 2021
  29. SHOHAM N, Eskinazi M, Hayes JF, Lewis G, et al
    Associations Between Psychosis and Visual Acuity Impairment: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 May 24. doi: 10.1111/acps.13330.
    PubMed     Abstract available


    April 2021
  30. MARWAHA S, Hett D, Johnson S, Fowler D, et al
    The impact of manic symptoms in first-episode psychosis: findings from the UK National EDEN study.
    Acta Psychiatr Scand. 2021 Apr 16. doi: 10.1111/acps.13307.
    PubMed     Abstract available


  31. SANKARANARAYANAN A, Pratt R, Anoop A, Smith A, et al
    Serum Lipids and Suicidal Risk among Patients with Schizophrenia Spectrum Disorders: Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 Apr 9. doi: 10.1111/acps.13305.
    PubMed     Abstract available


  32. WHISKEY E, Barnard A, Oloyede E, Dzahini O, et al
    An evaluation of the variation and underuse of clozapine in the United Kingdom.
    Acta Psychiatr Scand. 2021;143:339-347.
    PubMed     Abstract available


    March 2021
  33. VAN DER ZALM Y, Foldager L, Termorshuizen F, Sommer IE, et al
    Clozapine and mortality: A comparison with other antipsychotics in a nationwide Danish cohort study.
    Acta Psychiatr Scand. 2021;143:216-226.
    PubMed     Abstract available


  34. YADA Y, Kitagawa K, Sakamoto S, Ozawa A, et al
    The relationship between plasma clozapine concentration and clinical outcome: a cross-sectional study.
    Acta Psychiatr Scand. 2021;143:227-237.
    PubMed     Abstract available


    March 2020
  35. KAROW A, Brettschneider C, Helmut Konig H, Correll CU, et al
    Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychosis.
    Acta Psychiatr Scand. 2020;141:221-230.
    PubMed     Abstract available


  36. RUBIO JM, Kane JM
    How and when to use clozapine.
    Acta Psychiatr Scand. 2020;141:178-189.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: